MMP28 and neoplasm: In a patient-derived xenograft (PDX) model of PDAC, we analyzed the expression levels of MMP-28 in patients’ serum and PDX tumor tissues, and assessed the tumor’s sensitivity to Erlotinib (Fig. 5f and 5g).